Financial Analysis: CorVel (CRVL) & Its Peers
CorVel (NASDAQ: CRVL) is one of 45 public companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its competitors? We will compare CorVel to related businesses based on the strength of its institutional ownership, earnings, dividends, risk, profitability, valuation and analyst recommendations.
Institutional and Insider Ownership
43.6% of CorVel shares are held by institutional investors. Comparatively, 75.0% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 51.0% of CorVel shares are held by insiders. Comparatively, 13.0% of shares of all “Healthcare Facilities & Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This is a summary of current ratings for CorVel and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Healthcare Facilities & Services” companies have a potential upside of 6.49%. Given CorVel’s competitors higher probable upside, analysts plainly believe CorVel has less favorable growth aspects than its competitors.
This table compares CorVel and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings & Valuation
This table compares CorVel and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|CorVel||$518.69 million||$29.47 million||30.30|
|CorVel Competitors||$6.40 billion||$191.98 million||233.38|
CorVel’s competitors have higher revenue and earnings than CorVel. CorVel is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
CorVel has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, CorVel’s competitors have a beta of 0.70, meaning that their average stock price is 30% less volatile than the S&P 500.
CorVel competitors beat CorVel on 7 of the 10 factors compared.
CorVel Corporation (Corvel) is a provider of workers’ compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company’s network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company’s patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.